Windlas Biotech Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Windlas Biotech Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
quick-summary-circle
WINDLAS

Click to see a quick summary and important updates about this stock!Dismiss

Windlas Biotech Ltd.

BSE: 543329, NSE: WINDLAS

  • Market Capitalisation market-capitalisation-info ₹507 Cr

  • 12 Month Earnings monthly-earning ₹46 Cr
  • Price to Earnings price-to-earning 11.04

₹240.10

As on 23-Mar-2023 09:44 IST

up-down-arrow-1.05-0.44%

  • Prev Close info

    241.15

  • Day's Openinfo

    241.05

  • Today's Highinfo

    241.35

  • Today's Lowinfo

    239.70

  • Today's Volumeinfo

    1,816

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Windlas Biotech
-4.00 -3.19 -1.92 2.48 -- -- --
S&P BSE Healthcare
-5.97 -1.49 -8.01 -10.35 21.78 10.24 10.54
S&P BSE Small Cap
-5.89 -1.41 -4.22 -2.27 39.10 9.79 16.78
As on 23-Mar-2023
2022
Windlas Biotech
-9.37
S&P BSE Small Cap
-1.80
S&P BSE Healthcare
-12.10

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Windlas Biotech Ltd.

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis of Windlas Biotech Ltd.

        Incorporated

        2001

        Chairman

        Vivek Dhariwal

        Managing Director

        Hitesh Windlass

        Headquarters

        Dehradun, Uttarakhand
        Edit peer-selector-edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information ₹507.46 Cr
        • Revenue (TTM)revenue-information ₹494.50 Cr
        • Earnings (TTM) earning-information ₹45.97 Cr
        • Cash date-information ₹179.42 Cr
        • Total Debt info ₹6.12 Cr
        • Promoters' ownership promoters_ownership 60.75%
        • Liquidity liquidity High
        • 52 Week range week-range ₹203.25 - 284.00
        • Face value face-value ₹5.00
        • Shares outstanding share-outstanding 2,10,43,519
        • 10 Years Aggregate:

          CFO: ₹102.68 Cr

          EBITDA: ₹337.62 Cr

          Net Profit: ₹195.95 Cr

        About The Company

        • Business Manufacture of pharmaceuticals, medicinal chemical and botanical products
        • Incorporated 2001
        • Chairman Vivek Dhariwal
        • Managing Director Hitesh Windlass
        • Listing key-listing BSE: 543329, NSE: WINDLAS
        • Country India
        • Headquarters headquarters Dehradun, Uttarakhand
        • Website website www.windlasbiotech.com